Sheri Lewis' departure as Chief Operating Officer of SkinHealth Systems Inc. was reported; the filing names no successor. As of November 10, 2026, SkinHealth Systems Inc. has reported 5 leadership change filings to the SEC under Item 5.02 of Form 8-K, from April 22, 2026 to September 10, 2026, naming 1 appointment and 1 departure (Form 8-K, August 14, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like SkinHealth Systems Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-09-10
- · In / out: Out · Person: Sheri Lewis · Role: Chief Operating Officer · 8-K, 2026-08-14
- · In / out: Reported · Person: not named in the filing · 8-K/A, 2026-05-21
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-05-06
- · In / out: In · Person: Kenneth Tripp · Effective: 2026-04-17 · 8-K, 2026-04-22
SkinHealth Systems Inc. reported changes in 5 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-04-22 to 2026-09-10. They name 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as SkinHealth Systems Inc. files it.
Also on the record for SkinHealth Systems Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 9, 2026 | Stake report, Schedule 13G/A, by Integrated Core Strategies (US) LLC | 3.8% of the class | 5%+ stakes | Source |
| November 5, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 4.2% of the class | 5%+ stakes | Source |
| July 27, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 1% of the class | 5%+ stakes | Source |
| July 17, 2026 | Stake report, Schedule 13G, by BlackRock Portfolio Management LLC | 5.6% of the class | 5%+ stakes | Source |
| July 13, 2026 | Stake report, Schedule 13G/A, by Capricorn Fund Managers Ltd | 17.2% of the class | 5%+ stakes | Source |
| July 8, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 7.9% of the class | 5%+ stakes | Source |
| May 11, 2026 | Stake report, Schedule 13D/A, by Brian Miller | 25.74% of the class | 5%+ stakes | Source |
| May 6, 2026 | Stake report, Schedule 13G/A, by FMR LLC | 13.4% of the class | 5%+ stakes | Source |
| April 20, 2026 | Stake report, Schedule 13G, by Integrated Core Strategies (US) LLC | 5.1% of the class | 5%+ stakes | Source |
| February 6, 2026 | Stake report, Schedule 13G/A, by Mirabella Financial Services LLP | — | 5%+ stakes | Source |
| February 5, 2026 | Stake report, Schedule 13G, by Capricorn Fund Managers Ltd | 15.2% of the class | 5%+ stakes | Source |
| September 8, 2025 | Stake report, Schedule 13G/A, by Mirabella Financial Services LLP | 10.21% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs SkinHealth Systems Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on SkinHealth Systems Inc. and the records around it.
SkinHealth Systems Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
- Who owns it
Companies that share a holder
- Capricorn Fund Managers Ltd also filed stake reports on 3 other companies: Blend Labs, Inc. (Oct 2026), KINGSWAY Corp (Jul 2026), MAXCYTE, INC. (Feb 2026)
- Mirabella Financial Services LLP also filed stake reports on 3 other companies: Kingsway Financial Services Inc (Apr 2026), MAXCYTE, INC. (Apr 2026)
- Integrated Core Strategies (US) LLC also filed stake reports on 63 other companies: Infinite Eagle Acquisition Corp. (Nov 2026), Longeveron Inc. (Nov 2026), Edesa Biotech, Inc. (Nov 2026)
Watch SkinHealth Systems Inc.
Get an email when SkinHealth Systems Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on SkinHealth Systems Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on SkinHealth Systems Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on SkinHealth Systems Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
17 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 14 records.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-09-10 | Reported | not named in the filing | 8-K, 2026-09-10 | ||
| 2026-08-14 | Out | Chief Operating Officer | 8-K, 2026-08-14 | ||
| 2026-05-21 | Reported | not named in the filing | 8-K/A, 2026-05-21 | ||
| 2026-05-06 | Reported | not named in the filing | 8-K, 2026-05-06 | ||
| 2026-04-22 | In | 2026-04-17 | 8-K, 2026-04-22 |
Who leads SkinHealth Systems Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Operating Officer: Sheri Lewis, departure reported (filed 2026-08-14). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on SkinHealth Systems Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Operating Officer at SkinHealth Systems Inc., with the record behind each one.
Find candidates like Chief Operating Officer at SkinHealth Systems Inc.Every change, in the filing's words
Reported
Effective September 3, 2026, the Board of Directors of SkinHealth Systems Inc. (the "Company") promoted its Chief Financial Officer, Michael Monahan, to Chief Financial and Operating Officer (the "Promotion").
- In connection with Mr. Monahan's Promotion, he now oversees all of the Company's financial operations and the Company's supply chain, manufacturing, logistics, and customer experience.
- Effective September 15, 2026, Mr. Monahan's base salary will increase from $515,000 to $555,000 as a result of the Promotion.
- Biographical information for Mr. Monahan is contained in the Company's definitive proxy statement, filed with the U.S. Securities and Exchange Commission on April 24, 2026.
Departing: Sheri Lewis, Chief Operating Officer
Chief Operating Officer Departure On August 10, 2026, Sheri Lewis notified SkinHealth Systems Inc. (the "Company") of her decision to resign as its Chief Operations, Quality and Technology Officer to pursue other business opportunities outside of the Company.
- Effective August 28, 2026, Ms. Lewis will cease serving as the Company's Chief Operations, Quality and Technology Officer.
- Ms. Lewis' resignation is not the result of any disagreement with the Company, its Board of Directors, or Management on any matter relating to the Company's operations, policies, or practices.
Reported
Mr. Menezes' termination was not a result of any disagreement with the Company on any matter relating to the Company's financial reporting, operations, policies or practices.
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
- Chief Revenue Officer Departure On May 5, 2026, the Board of Directors of the Company terminated Ronald Menezes' employment as Chief Revenue Officer of the Company without cause, effective as of May 6, 2026.
- On May 15, 2026, the parties entered into the Separation Agreement in connection with Mr. Menezes' termination from his position as Chief Revenue Officer of the Company.
- Pursuant to the Separation Agreement, Mr. Menezes' position with the Company terminated effective May 6, 2026 (the "Separation Date").
- The Separation Agreement further provides that commencing on the first day of the month following the Separation Date, Mr. Menezes may elect to continue his health, dental, and vision benefits under the Company's group health plans under COBRA continuation coverage.
- If Mr. Menezes timely submits an election to continue coverage under COBRA, the Company will reimburse the employer portion of COBRA premium payments during the period that Mr. Menezes receives the Severance Benefits.
- As consideration for the Severance Benefits, Mr. Menezes agreed to release all claims against the Company and related releasees arising out of or in any way connected with Mr. Menezes' employment relationship with the Company or his separation from employment.
Reported
Mr. Menezes' termination was not a result of any disagreement with the Company on any matter relating to the Company's financial reporting, operations, policies or practices.
- Chief Revenue Officer Departure On May 5, 2026, the Board of Directors of SkinHealth Systems Inc. (the "Company") terminated Mr. Ronald Menezes' employment as Chief Revenue Officer of the Company without cause, effective as of May 5, 2026.
- The Company intends to enter into a separation agreement with Mr. Menezes as soon as practicable in connection with his termination as Chief Revenue Officer of the Company that will document any applicable payments or benefits to be provided to him in respect of such termination.
Appointed: Kenneth Tripp, effective 2026-04-17
On April 17, 2026, at the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the "Board") of The Beauty Health Company (the "Company"), the Board appointed Mr. Kenneth Tripp to fill the single vacancy on the Board effective as of April 17, 2026, increased the number of members of the Board from nine (9) to eleven (11) effective as of April 17, 2026, and appointed Dr. Sachin Shridharani and Mr. E. Scott Beattie to fill those two new vacancies on the Board, effective as of April 17, 2026.
- Kenneth Tripp, 59, currently serves as the Senior Vice President of Global Operations and Logistics at Zimmer Biomet Holdings, Inc. ("Zimmer Biomet"), a publicly traded medical device company, where he leads manufacturing, supply chain, engineering, and commercial operations, a role he has held since 2018.
- During his time at Zimmer Biomet, Mr. Tripp has successfully led the integration, optimization, and expansion of Zimmer Biomet's global operations network.
- From July 2017 to February 2018, Mr. Tripp served as Senior Vice President of Manufacturing at Cardinal Health Technologies, LLC and was responsible for the manufacturing of medical supplies and patient care products across sixteen sites globally.
- Prior to his time at Cardinal Health Technologies, LLC, Mr. Tripp held senior manufacturing and supply chain roles with Covidien plc (now Medtronic plc), where he was responsible for managing large-scale and complex manufacturing operations and supply chains for various divisions, product lines, and geographies.
- Mr. Tripp retired from the US Navy and Navy Reserve after 25 years of service in 2009 and holds a Master of Business Administration with a focus on organizational leadership from Ashford University.
Tools for this story
Each opens in a new tab, filled in for SkinHealth Systems Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.